Annals of Surgical Oncology Cite Track
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ollila, D. W.
Right arrow Articles by Morton, D. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ollila, D. W.
Right arrow Articles by Morton, D. L.

Annals of Surgical Oncology, Vol 6, Issue 2 150-154, Copyright © 1999 by Society of Surgical Oncology

ARTICLES

Parotid region lymphatic mapping and sentinel lymphadenectomy for cutaneous melanoma

D. W. Ollila, L. J. Foshag, R. Essner, S. L. Stern and D. L. Morton
Roy E. Coats Research Laboratories of the John Wayne Cancer Institute, St. John's Health Center, Santa Monica, California 90404, USA.

BACKGROUND: Routine elective superficial parotidectomy for patients with primary cutaneous melanomas of the scalp, auricle, or face has been questioned. We evaluated an alternative, i.e., lymphatic mapping and sentinel lymphadenectomy, for patients with primary cutaneous melanomas draining to the region of the parotid gland. PATIENTS: Retrospective review of our large (>8000 patients) melanoma database identified 39 patients with primary melanomas (American Joint Committee on Cancer stage I or II) of the scalp (n = 19), auricle (n = 11), or face (n = 9) who underwent intraoperative lymphatic mapping to identify a sentinel node (SN) in the region of the parotid gland, between June 1985 and July 1997. RESULTS: A SN was identified in the parotid region of 37 patients (94.9%), four of whom had SN metastases. The mean number of SN obtained was 2.3/patient (range, 1-4/patient). The two patients (5.1%) for whom a parotid-region SN could not be identified underwent superficial parotidectomy during the same operation. Among the 33 patients with tumor-free SN, with a median follow-up period of 33.2 months (range, 1-121 months), there was one (3.1%) intraparotid recurrence; thus, the false-negative rate was 3.1%. The procedure-related surgical morbidity rate was only 2.6% (one case of temporary facial nerve paresis). CONCLUSIONS: For patients with primary melanomas of the scalp, auricle, or face, sentinel lymphadenectomy can be performed accurately in the parotid region and offers a low-morbidity alternative to routine elective superficial parotidectomy.


This article has been cited by other articles:


Home page
 Arch SurgHome page
J. B. Roaten, N. Pearlman, R. Gonzalez, R. Gonzalez, and M. D. McCarter
Identifying Risk Factors for Complications Following Sentinel Lymph Node Biopsy for Melanoma
Arch Surg, January 1, 2005; 140(1): 85 - 89.
[Abstract] [Full Text] [PDF]

Home page
 Arch Otolaryngol Head Neck SurgHome page
T. R. Fincher, J. C. O'Brien, T. M. McCarty, T. L. Fisher, J. T. Preskitt, Z. H. Lieberman, J. F. Stephens, and J. A. Kuhn
Patterns of Drainage and Recurrence Following Sentinel Lymph Node Biopsy for Cutaneous Melanoma of the Head and Neck
Arch Otolaryngol Head Neck Surg, July 1, 2004; 130(7): 844 - 848.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
W. R. Wrightson, S. L. Wong, M. J. Edwards, C. Chao, D. S. Reintgen, M. I. Ross, R. D. Noyes, V. Viar, P. B. Cerrito, and K. M. McMasters
Complications Associated With Sentinel Lymph Node Biopsy for Melanoma
Ann. Surg. Oncol., July 1, 2003; 10(6): 676 - 680.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
B. A. Pockaj, D. E. Jaroszewski, D. J. DiCaudo, J. G. Hentz, E. W. Buchel, R. J. Gray, S. N. Markovic, and U. Bite
Changing Surgical Therapy for Melanoma of the External Ear
Ann. Surg. Oncol., July 1, 2003; 10(6): 689 - 696.
[Abstract] [Full Text] [PDF]

Home page
 Arch Otolaryngol Head Neck SurgHome page
C. E. Schmalbach, B. Nussenbaum, R. S. Rees, J. Schwartz, T. M. Johnson, and C. R. Bradford
Reliability of Sentinel Lymph Node Mapping With Biopsy for Head and Neck Cutaneous Melanoma
Arch Otolaryngol Head Neck Surg, January 1, 2003; 129(1): 61 - 65.
[Abstract] [Full Text] [PDF]

Home page
 Arch Otolaryngol Head Neck SurgHome page
S. G. Patel, D. G. Coit, A. R. Shaha, M. S. Brady, J. O. Boyle, B. Singh, J. P. Shah, and D. H. Kraus
Sentinel Lymph Node Biopsy for Cutaneous Head and Neck Melanomas
Arch Otolaryngol Head Neck Surg, March 1, 2002; 128(3): 285 - 291.
[Abstract] [Full Text] [PDF]

Home page
 Arch Otolaryngol Head Neck SurgHome page
J. D. Wagner, H.-M. Park, J. J. Coleman III, C. Love, and J. T. Hayes
Cervical Sentinel Lymph Node Biopsy for Melanomas of the Head and Neck and Upper Thorax
Arch Otolaryngol Head Neck Surg, March 1, 2000; 126(3): 313 - 321.
[Abstract] [Full Text] [PDF]

Home page
 Arch Otolaryngol Head Neck SurgHome page
G. W. Carlson, D. R. Murray, R. Greenlee, N. Alazraki, C. Fry-Spray, R. Poole, M. Blais, A. Hestley, and J. Vansant
Management of Malignant Melanoma of the Head and Neck Using Dynamic Lymphoscintigraphy and Gamma Probe-Guided Sentinel Lymph Node Biopsy
Arch Otolaryngol Head Neck Surg, March 1, 2000; 126(3): 433 - 437.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the Society of Surgical Oncology.